The global Human DNA Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.
This report aims to provide a comprehensive presentation of the global market for Human DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human DNA Vaccines. This report contains market size and forecasts of Human DNA Vaccines in global, including the following market information:
- Global Human DNA Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Recombinant Protein Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human DNA Vaccines include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human DNA Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human DNA Vaccines Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Human DNA Vaccines Market Segment Percentages, by Type, 2022 (%)
- Recombinant Protein Vaccine
- Gene-Based Vaccine
Global Human DNA Vaccines Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Human DNA Vaccines Market Segment Percentages, by Application, 2022 (%)
- Influenza
- Human Papillomavirus
- HIV
Global Human DNA Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Human DNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Human DNA Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Human DNA Vaccines revenues share in global market, 2022 (%)
Key players include:
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer-Ingelheim
- Indian Immunologicals
- Plumbline Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human DNA Vaccines, market overview.
Chapter 2: Global Human DNA Vaccines market size in revenue.
Chapter 3: Detailed analysis of Human DNA Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human DNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human DNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human DNA Vaccines Overall Market Size
2.1 Global Human DNA Vaccines Market Size: 2022 VS 2032
2.2 Global Human DNA Vaccines Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human DNA Vaccines Players in Global Market
3.2 Top Global Human DNA Vaccines Companies Ranked by Revenue
3.3 Global Human DNA Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Human DNA Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human DNA Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human DNA Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Human DNA Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Human DNA Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human DNA Vaccines Market Size Markets, 2022 & 2032
4.1.2 Recombinant Protein Vaccine
4.1.3 Gene-Based Vaccine
4.2 By Type - Global Human DNA Vaccines Revenue & Forecasts
4.2.1 By Type - Global Human DNA Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Human DNA Vaccines Revenue, 2024-2032
4.2.3 By Type - Global Human DNA Vaccines Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human DNA Vaccines Market Size, 2022 & 2032
5.1.2 Influenza
5.1.3 Human Papillomavirus
5.1.4 HIV
5.2 By Application - Global Human DNA Vaccines Revenue & Forecasts
5.2.1 By Application - Global Human DNA Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Human DNA Vaccines Revenue, 2024-2032
5.2.3 By Application - Global Human DNA Vaccines Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Human DNA Vaccines Market Size, 2022 & 2032
6.2 By Region - Global Human DNA Vaccines Revenue & Forecasts
6.2.1 By Region - Global Human DNA Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Human DNA Vaccines Revenue, 2024-2032
6.2.3 By Region - Global Human DNA Vaccines Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Human DNA Vaccines Revenue, 2018-2032
6.3.2 US Human DNA Vaccines Market Size, 2018-2032
6.3.3 Canada Human DNA Vaccines Market Size, 2018-2032
6.3.4 Mexico Human DNA Vaccines Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Human DNA Vaccines Revenue, 2018-2032
6.4.2 Germany Human DNA Vaccines Market Size, 2018-2032
6.4.3 France Human DNA Vaccines Market Size, 2018-2032
6.4.4 U.K. Human DNA Vaccines Market Size, 2018-2032
6.4.5 Italy Human DNA Vaccines Market Size, 2018-2032
6.4.6 Russia Human DNA Vaccines Market Size, 2018-2032
6.4.7 Nordic Countries Human DNA Vaccines Market Size, 2018-2032
6.4.8 Benelux Human DNA Vaccines Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Human DNA Vaccines Revenue, 2018-2032
6.5.2 China Human DNA Vaccines Market Size, 2018-2032
6.5.3 Japan Human DNA Vaccines Market Size, 2018-2032
6.5.4 South Korea Human DNA Vaccines Market Size, 2018-2032
6.5.5 Southeast Asia Human DNA Vaccines Market Size, 2018-2032
6.5.6 India Human DNA Vaccines Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Human DNA Vaccines Revenue, 2018-2032
6.6.2 Brazil Human DNA Vaccines Market Size, 2018-2032
6.6.3 Argentina Human DNA Vaccines Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human DNA Vaccines Revenue, 2018-2032
6.7.2 Turkey Human DNA Vaccines Market Size, 2018-2032
6.7.3 Israel Human DNA Vaccines Market Size, 2018-2032
6.7.4 Saudi Arabia Human DNA Vaccines Market Size, 2018-2032
6.7.5 UAE Human DNA Vaccines Market Size, 2018-2032
7 Human DNA Vaccines Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Human DNA Vaccines Major Product Offerings
7.1.4 Merck Human DNA Vaccines Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Human DNA Vaccines Major Product Offerings
7.2.4 GSK Human DNA Vaccines Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human DNA Vaccines Major Product Offerings
7.3.4 Sanofi Human DNA Vaccines Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Zoties
7.4.1 Zoties Company Summary
7.4.2 Zoties Business Overview
7.4.3 Zoties Human DNA Vaccines Major Product Offerings
7.4.4 Zoties Human DNA Vaccines Revenue in Global Market (2018-2023)
7.4.5 Zoties Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Human DNA Vaccines Major Product Offerings
7.5.4 Elanco Human DNA Vaccines Revenue in Global Market (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Boehringer-Ingelheim
7.6.1 Boehringer-Ingelheim Company Summary
7.6.2 Boehringer-Ingelheim Business Overview
7.6.3 Boehringer-Ingelheim Human DNA Vaccines Major Product Offerings
7.6.4 Boehringer-Ingelheim Human DNA Vaccines Revenue in Global Market (2018-2023)
7.6.5 Boehringer-Ingelheim Key News & Latest Developments
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Company Summary
7.7.2 Indian Immunologicals Business Overview
7.7.3 Indian Immunologicals Human DNA Vaccines Major Product Offerings
7.7.4 Indian Immunologicals Human DNA Vaccines Revenue in Global Market (2018-2023)
7.7.5 Indian Immunologicals Key News & Latest Developments
7.8 Plumbline Life Sciences
7.8.1 Plumbline Life Sciences Company Summary
7.8.2 Plumbline Life Sciences Business Overview
7.8.3 Plumbline Life Sciences Human DNA Vaccines Major Product Offerings
7.8.4 Plumbline Life Sciences Human DNA Vaccines Revenue in Global Market (2018-2023)
7.8.5 Plumbline Life Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human DNA Vaccines Market Opportunities & Trends in Global Market
Table 2. Human DNA Vaccines Market Drivers in Global Market
Table 3. Human DNA Vaccines Market Restraints in Global Market
Table 4. Key Players of Human DNA Vaccines in Global Market
Table 5. Top Human DNA Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human DNA Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human DNA Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human DNA Vaccines Product Type
Table 9. List of Global Tier 1 Human DNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human DNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human DNA Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Human DNA Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human DNA Vaccines Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Human DNA Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Human DNA Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human DNA Vaccines Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Human DNA Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Human DNA Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human DNA Vaccines Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Human DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human DNA Vaccines Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Human DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human DNA Vaccines Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Human DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human DNA Vaccines Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Human DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human DNA Vaccines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Human DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human DNA Vaccines Revenue, (US$, Mn), 2024-2032
Table 30. Merck Company Summary
Table 31. Merck Human DNA Vaccines Product Offerings
Table 32. Merck Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. GSK Company Summary
Table 35. GSK Human DNA Vaccines Product Offerings
Table 36. GSK Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. GSK Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Human DNA Vaccines Product Offerings
Table 40. Sanofi Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Zoties Company Summary
Table 43. Zoties Human DNA Vaccines Product Offerings
Table 44. Zoties Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Zoties Key News & Latest Developments
Table 46. Elanco Company Summary
Table 47. Elanco Human DNA Vaccines Product Offerings
Table 48. Elanco Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Elanco Key News & Latest Developments
Table 50. Boehringer-Ingelheim Company Summary
Table 51. Boehringer-Ingelheim Human DNA Vaccines Product Offerings
Table 52. Boehringer-Ingelheim Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer-Ingelheim Key News & Latest Developments
Table 54. Indian Immunologicals Company Summary
Table 55. Indian Immunologicals Human DNA Vaccines Product Offerings
Table 56. Indian Immunologicals Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Indian Immunologicals Key News & Latest Developments
Table 58. Plumbline Life Sciences Company Summary
Table 59. Plumbline Life Sciences Human DNA Vaccines Product Offerings
Table 60. Plumbline Life Sciences Human DNA Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Plumbline Life Sciences Key News & Latest Developments
List of Figures
Figure 1. Human DNA Vaccines Segment by Type in 2022
Figure 2. Human DNA Vaccines Segment by Application in 2022
Figure 3. Global Human DNA Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human DNA Vaccines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Human DNA Vaccines Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human DNA Vaccines Revenue in 2022
Figure 8. By Type - Global Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 9. By Application - Global Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 10. By Type - Global Human DNA Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 12. By Application - Global Human DNA Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 14. By Region - Global Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 15. By Country - North America Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 16. US Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 20. Germany Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 21. France Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 28. China Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 32. India Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 34. Brazil Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Human DNA Vaccines Revenue Market Share, 2018-2032
Figure 37. Turkey Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Human DNA Vaccines Revenue, (US$, Mn), 2018-2032
Figure 41. Merck Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GSK Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zoties Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Elanco Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer-Ingelheim Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Indian Immunologicals Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Plumbline Life Sciences Human DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
